Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Buy

A

Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR)

https://www.pharming.com

Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/23/2020

Market Cap

525,256,286

Shares Outstanding

671,070,000

Weighted SO

65,917,843

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

GLSH --.--%

ELYM --.--%

GNTA --.--%

OPT --.--%

PRDS --.--%

MLYS --.--%

ANEB --.--%

JANX --.--%

Beta

0.8060

Last Div

0.0000

Range

6.65-16.71

Chg

0.1331

Avg Vol

6837

Mkt Cap

525256286

Exch

NASDAQ

Country

NL

Phone

31 71 524 7400

DCF Diff

-7.6375

DCF

15.3806

Div Yield

0.0000

P/S

1.8893

EV Multiple

561.7560

P/FV

2.5031

Div Yield %

0.0000

P/E

-40.7941

PEG

-5.2023

Payout

0.0000

Current Ratio

3.3856

Quick Ratio

2.6451

Cash Ratio

0.5897

DSO

67.1134

DIO

547.9286

Op Cycle

615.0420

DPO

675.4639

CCC

-60.4219

Gross Margin

0.8582

Op Margin

-0.0651

Pretax Margin

-0.0546

Net Margin

-0.0463

Eff Tax Rate

0.1661

ROA

-0.0310

ROE

-0.0610

ROCE

-0.0539

NI/EBT

0.8490

EBT/EBIT

0.8379

EBIT/Rev

-0.0651

Debt Ratio

0.2534

D/E

0.5022

LT Debt/Cap

0.3193

Total Debt/Cap

0.3343

Int Coverage

-2.4302

CF/Debt

-0.0678

Equity Multi

1.9821

Rec Turnover

5.4386

Pay Turnover

0.5404

Inv Turnover

0.6661

FA Turnover

9.0487

Asset Turnover

0.6684

OCF/Share

-0.1053

FCF/Share

-0.1167

Cash/Share

2.3634

OCF/Sales

-0.0257

FCF/OCF

1.1080

CF Coverage

-0.0678

ST Coverage

-1.0253

CapEx Coverage

-9.2572

Div&CapEx Cov

-9.2572

P/BV

2.5031

P/B

2.5031

P/S

1.8893

P/E

-40.7941

P/FCF

-66.3344

P/OCF

-73.5001

P/CF

-73.5001

PEG

-5.2023

P/S

1.8893

EV Multiple

561.7560

P/FV

2.5031

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 15, 18:45 Pharming announces public cash offer to the shareholders of Abliva AB

Revenue Product Segmentation